½ÃÀ庸°í¼­
»óǰÄÚµå
1618240

½º¸¶Æ® ÀÇ·á±â±â ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)

Smart Medical Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ½º¸¶Æ® ÀÇ·á±â±â ½ÃÀåÀº 2023³â 380¾ï ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇß°í, 2024-2032³â°£ ¿¬Æò±Õ 14.3%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ÀÌ·¯ÇÑ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀº ½º¸¶Æ®Æù Áö¿ø ÀÇ·á±â±â ¹× ¹«¼± ÀÇ·á±â±âÀÇ Ã¤Åà Áõ°¡¿Í °Ç°­ ¹× ÇÇÆ®´Ï½º¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, ¸¸¼ºÁúȯÀÇ È®»ê, ÀÇ·áºñ Áõ°¡, ¿þ¾î·¯ºí ±â±â¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä µî ¿©·¯ ¿äÀÎÀÌ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ º´¿ø°ú Áø´Ü¼¾ÅÍ¿¡¼­ Áø´Ü ¹× Ä¡·á¸¦ À§ÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼­ ½º¸¶Æ® ÀÇ·á±â±âÀÇ Àü¸Áµµ ¹à¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü°ú ȯÀÚ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ µµÀÔµµ ½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº Áø´Ü ¹× ¸ð´ÏÅ͸µ ±â±â, Ä¡·á ±â±â, ±âŸ °ü·Ã Á¦Ç° µî ¿©·¯ Á¦Ç° À¯ÇüÀ¸·Î ³ª´¹´Ï´Ù. Áø´Ü ¹× ¸ð´ÏÅ͸µ ºÎ¹®¸¸ ³õ°í º¸¸é 2023³â ½ÃÀå ±Ô¸ð´Â 258¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ºÎ¹®¿¡´Â Ç÷´ç ¸ð´ÏÅÍ, ½É¹Ú¼ö ¸ð´ÏÅÍ, ¸Æ¹Ú »ê¼Ò ÃøÁ¤±â, Ç÷¾Ð ¸ð´ÏÅÍ, È£Èí ºÐ¼®±â µî ´Ù¾çÇÑ ±â±â°¡ Æ÷ÇԵ˴ϴÙ. Ä¡·á ±â±â Ä«Å×°í¸®¿¡´Â ÈÞ´ë¿ë »ê¼Ò ³óÃà±â, ÀΰøÈ£Èí±â, Àν¶¸° ÆßÇÁ, º¸Ã»±â µîÀÌ Æ÷ÇԵ˴ϴÙ. ½º¸¶Æ® ÀÇ·á±â±â¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ÇÔ²² ȯÀÚ Ä¡·á¸¦ °­È­Çϱâ À§ÇÑ Á¤ºÎ Áö¿øÃ¥ÀÌ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ÀÇ·á±â±â À¯Åë ä³ÎÀº ÀüÅëÀûÀÎ ¼Ò¸Å ¹× ÀüÀÚ»ó°Å·¡·Î ³ª´µ¸ç, ÀüÀÚ»ó°Å·¡´Â °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ºÐ¾ß·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È 17.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¹è°æ¿¡´Â ½º¸¶Æ®Æù¿¡ ÀÇÇÑ ¿Â¶óÀÎ ¼îÇÎ Áõ°¡ Ãß¼¼°¡ ÀÖ½À´Ï´Ù. ¿Â¶óÀÎ À¯Åë ä³Î·ÎÀÇ ÀüȯÀº Áý¿¡¼­ ±¸¸ÅÇÒ ¼ö ÀÖ´Â ÆíÀǼº, ´Ù¾çÇÑ Á¦Ç°, °¡°Ý ºñ±³ ¹× ¸®ºä °Ë»öÀÌ °¡´ÉÇÑ Á¡ µîÀÌ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2023³â
¿¹Ãø ¿¬µµ 2024-2032³â
½ÃÀÛ °¡°Ý 380¾ï ´Þ·¯
¿¹ÃøÄ¡ 1,292¾ï ´Þ·¯
CAGR 14.3%

ÀüÀÚ»ó°Å·¡ Ç÷§ÆûÀº ¿øÈ°ÇÑ ±¸¸Å °æÇèÀ» ÃËÁøÇÏ¿© ȯÀÚ°¡ ¿ÀÇÁ¶óÀÎ ¸ÅÀåÀ̳ª ÀÇ·á ½Ã¼³À» ¹æ¹®ÇÏÁö ¾Ê°íµµ ½º¸¶Æ® ÀÇ·á±â±â¸¦ ±¸ÀÔÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ºÏ¹Ì ½º¸¶Æ® ÀÇ·á±â±â ½ÃÀåÀº 2023³â 139¾ï ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÇâÈÄ ¸î ³âµ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ÀÌ Áö¿ªÀº ÀÇ·á ±â¼ú Çõ½ÅÀÇ ¼±µÎÁÖÀÚÀ̸ç, ´Ù¾çÇÑ ¿äÀεéÀÌ ½º¸¶Æ® ÀÇ·á±â±âÀÇ ¹ßÀü°ú º¸±Þ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¿þ¾î·¯ºí ±â¼ú°ú ¼¾¼­ÀÇ Á¤È®µµ µî ÁÖ¿ä ±â¼úÀÇ ¹ßÀüÀº º¸´Ù È¿°úÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ÀÇ·á ¼Ö·ç¼ÇÀÇ ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • »ê¾÷¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ´ç´¢º´, õ½Ä, ±âŸ Áúȯ À¯º´·ü Áõ°¡
      • ÀÇ·á±â±â »ê¾÷ ȰȲ
      • ÀÎÅÍ³Ý º¸±Þ·ü »ó½Â°ú ºòµ¥ÀÌÅÍ µµÀÔ
      • Áø´Ü°ú Ä¡·á¸¦ À§ÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ ±¸µ¿Çü Á¢±Ù Á߿伺 Áõ°¡
    • »ê¾÷ÀÇ ÀáÀçÀû ¸®½ºÅ©¿Í °úÁ¦
      • ÇÁ¶óÀ̹ö½Ã¿¡ °üÇÑ ¿ì·Á
      • ÁßÀú ¼Òµæ±¹ ÀûÀýÇÑ ÀÎÇÁ¶ó °á¿©
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • »óȯ ½Ã³ª¸®¿À
  • ±â¼úÀû Àü¸Á
  • °¡°Ý ºÐ¼®
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • °ø±Þ¾÷ü »óȲ
  • ÀμöÇÕº´(M&A)Ȱµ¿
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • °¸ ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Á¦Ç° À¯Çüº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • Áø´Ü¡¤¸ð´ÏÅ͸µ ±â±â
    • Ç÷´ç ¸ð´ÏÅÍ
    • ½É¹Ú¼ö ¸ð´ÏÅÍ
    • ÆÞ½º¿Á½Ã¹ÌÅÍ
    • Ç÷¾Ð ¸ð´ÏÅÍ
    • À½ÁÖ °¨Áö±â
    • ±âŸ Áø´Ü¡¤¸ð´ÏÅ͸µ ±â±â
  • Ä¡·á ±â±â
    • ÈÞ´ë¿ë »ê¼Ò¹ß»ý±â¿Í ÀΰøÈ£Èí±â
    • Àν¶¸° ÆßÇÁ
    • º¸Ã»±â
    • ±âŸ Ä¡·á ±â±â
  • ±âŸ

Á¦6Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ÀçÅÃÄ¡·á
  • ±âŸ

Á¦7Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : À¯Åë ä³Îº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ½ÇÁ¡Æ÷
  • E-Commerce

Á¦8Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦9Àå ±â¾÷ °³¿ä

  • Abbott
  • Apple
  • Biobeat
  • Boston Scientific Corporation
  • Dexcom
  • F Hoffmann-La Roche
  • Fitbit
  • Medtronic
  • NeuroMetrix
  • Novo Nordisk
  • Omron Corporation
  • SAMSUNG
  • VitalConnect
  • West Pharmaceutical Services
LSH 25.01.09

The Global Smart Medical Devices Market was worth USD 38 billion in 2023 and is anticipated to grow at 14.3% CAGR throughout 2024-2032. This impressive growth is driven by the rising adoption of smartphone-compatible and wireless medical devices, as well as an increasing focus on health and fitness. Several factors are propelling the market forward, including heightened healthcare concerns, the growing prevalence of chronic diseases, rising healthcare expenditures, and a significant demand for wearable devices. The emphasis on real-time data for diagnostics and treatment in hospitals and diagnostic centers is also enhancing the prospects for smart medical devices. Additionally, ongoing technological advancements in healthcare and the implementation of innovative solutions to improve patient outcomes are key contributors to the market's expansion.

The market is categorized into several product types, including diagnostic and monitoring devices, therapeutic devices, and other related products. The diagnostic and monitoring segment alone was valued at USD 25.8 billion in 2023. This segment encompasses a variety of devices, such as blood glucose monitors, heart rate monitors, pulse oximeters, blood pressure monitors, and breathalyzers. The therapeutic devices category includes portable oxygen concentrators, ventilators, insulin pumps, and hearing aids. Supportive government initiatives aimed at enhancing patient care, along with increased investments in smart medical devices, are driving the growth of these segments.

Distribution channels for these devices are divided into traditional retail and e-commerce. E-commerce is emerging as the fastest-growing segment, with an impressive CAGR of 17.1% projected during the forecast period. This growth can be attributed to the rising trend of online shopping via smartphones, which offers consumers greater flexibility and access to a broader range of products. The shift toward online sales channels is influenced by the convenience of purchasing from home, the variety of products available, and the ability to compare prices and read reviews.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$38 Billion
Forecast Value$129.2 Billion
CAGR14.3%

E-commerce platforms facilitate a seamless purchasing experience, allowing patients to obtain smart medical devices without the need to visit physical stores or healthcare facilities. North American smart medical devices market generated revenues of USD 13.9 billion in 2023 and is poised for significant growth in the coming years. This region stands as a leader in healthcare technology innovation, where various factors are contributing to the advancement and widespread adoption of smart medical devices. Key technological advancements, particularly in wearable technology and sensor accuracy, are paving the way for more effective and reliable medical solutions.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of diabetes, asthma and other diseases
      • 3.2.1.2 Booming medical device industry
      • 3.2.1.3 Increasing internet penetration rate and adoption of big data
      • 3.2.1.4 Rising importance of real time data driven approach for diagnostics and treatment
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Privacy concerns
      • 3.2.2.2 Lack of suitable infrastructure in low- and middle-income countries
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Technological landscape
  • 3.7 Pricing analysis
  • 3.8 Future market trends
  • 3.9 Supplier landscape
  • 3.10 M&A activities
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis
  • 3.13 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostic and monitoring devices
    • 5.2.1 Blood glucose monitors
    • 5.2.2 Heart rate monitors
    • 5.2.3 Pulse oximeters
    • 5.2.4 Blood pressure monitors
    • 5.2.5 Breathalyzers
    • 5.2.6 Other diagnostic and monitoring devices
  • 5.3 Therapeutic devices
    • 5.3.1 Portable oxygen concentrators and ventilators
    • 5.3.2 Insulin pumps
    • 5.3.3 Hearing aid
    • 5.3.4 Other therapeutic devices
  • 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Homecare settings
  • 6.4 Other End Use

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Brick & mortar
  • 7.3 E-commerce

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott
  • 9.2 Apple
  • 9.3 Biobeat
  • 9.4 Boston Scientific Corporation
  • 9.5 Dexcom
  • 9.6 F Hoffmann-La Roche
  • 9.7 Fitbit
  • 9.8 Medtronic
  • 9.9 NeuroMetrix
  • 9.10 Novo Nordisk
  • 9.11 Omron Corporation
  • 9.12 SAMSUNG
  • 9.13 VitalConnect
  • 9.14 West Pharmaceutical Services
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦